TY - JOUR
T1 - Survival comparison between superficialization of the brachial artery and tunneled central venous catheter placement in hemodialysis patients with heart failure
T2 - A retrospective study
AU - Nakagawa, Kaneyasu
AU - Yamada, Shunsuke
AU - Matsukuma, Yuta
AU - Nakano, Toshiaki
AU - Mitsuiki, Koji
N1 - Funding Information:
The authors thank the following doctors (institutions) who participated in this study: Koichiro Goto (Goto Clinic), Gishichiro Konomi (Hakujinkai Hospital), Yoshio Horita (Kaizuka Hospital), Hiroaki Takamura (Keikokai Hara Hospital), Yoichi Miyauchi (Miyauchi Internal Circulatory Clinic), Isao Michinaga (Murayama Urology Clinic), Koichi Nakashima (Ohashi Internal Circulatory Clinic), Masaru Shigematsu (Shigematsu Clinic), and Goro Shinagawa (Shinagawa Surgical Hospital). We thank Nancy Schatken, BS, MT(ASCP), from Edanz Group (www.edanzediting.com/ac), for editing a draft of this manuscript.
Publisher Copyright:
© 2019 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy
PY - 2020/8/1
Y1 - 2020/8/1
N2 - It remains unclear which vascular access provides better survival in hemodialysis patients with heart failure, superficialization of the brachial artery (SBA), or tunneled central venous catheter (TCVC). We retrospectively followed up 60 hemodialysis patients with heart failure who underwent SBA (n = 36) or TCVC placement (n = 24). During the median 2.2-year follow-up period, 36 patients died. The median survival time was significantly longer for the SBA group than for the TCVC group (5.7 vs 1.7 years; P <.05, log-rank test). A multivariate-adjusted Cox regression analysis showed that SBA was associated with a reduced risk of all-cause death (hazard ratio [HR] 0.30; 95% confidence interval [CI] 0.14-0.65). In the cohort of propensity score-matched 15 pairs, patients with SBA experienced fewer all-cause deaths (HR 0.29; 95% CI 0.10-0.77). Our study suggests that SBA is an alternative option in hemodialysis patients with heart failure.
AB - It remains unclear which vascular access provides better survival in hemodialysis patients with heart failure, superficialization of the brachial artery (SBA), or tunneled central venous catheter (TCVC). We retrospectively followed up 60 hemodialysis patients with heart failure who underwent SBA (n = 36) or TCVC placement (n = 24). During the median 2.2-year follow-up period, 36 patients died. The median survival time was significantly longer for the SBA group than for the TCVC group (5.7 vs 1.7 years; P <.05, log-rank test). A multivariate-adjusted Cox regression analysis showed that SBA was associated with a reduced risk of all-cause death (hazard ratio [HR] 0.30; 95% confidence interval [CI] 0.14-0.65). In the cohort of propensity score-matched 15 pairs, patients with SBA experienced fewer all-cause deaths (HR 0.29; 95% CI 0.10-0.77). Our study suggests that SBA is an alternative option in hemodialysis patients with heart failure.
UR - http://www.scopus.com/inward/record.url?scp=85076743518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076743518&partnerID=8YFLogxK
U2 - 10.1111/1744-9987.13457
DO - 10.1111/1744-9987.13457
M3 - Article
C2 - 31730268
AN - SCOPUS:85076743518
SN - 1744-9979
VL - 24
SP - 408
EP - 415
JO - Therapeutic Apheresis and Dialysis
JF - Therapeutic Apheresis and Dialysis
IS - 4
ER -